Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vesicular integral-membrane protein VIP36 (LMAN2) is a type I transmembrane lectin that functions as an intracellular lectin in the early secretory pathway. It binds to high-mannose type glycoproteins and shuttles between the endoplasmic reticulum and Golgi apparatus, thereby playing a role in protein sorting and trafficking. There is no current evidence that it serves as a therapeutic target or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vesicular integral-membrane protein VIP36 (LMAN2).